| Medical and Health Sciences | Lifetime | 945 | NL 26 | 99.96 |
| Agricultural, Food and Veterinary Sciences | Lifetime | 574 | NL 23 | 99.54 |
| Medical and Health Sciences | 2021-2025 | 395 | NL 10 | 99.92 |
| Infectious Diseases | Lifetime | 9 | NL 1 | 99.95 |
| Epidemiology | Lifetime | 331 | NL 8 | 99.60 |
| Public, Environmental and Occupational Health | Lifetime | 648 | NL 20 | 99.09 |
| Animal Science and Livestock Production | Lifetime | 247 | NL 7 | 98.34 |
| Agronomy and Crop Science | Lifetime | 509 | NL 15 | 96.39 |
| Hepatology | Lifetime | 555 | NL 5 | 92.79 |
| Infectious Diseases | 2021-2025 | 15 | NL 1 | 99.79 |
| Public, Environmental and Occupational Health | 2021-2025 | 28 | NL 1 | 99.70 |
| Epidemiology | 2021-2025 | 223 | NL 4 | 98.35 |
| Virology | 2021-2025 | 46 | NL 2 | 90.92 |
| Viral gastroenteritis research and epidemiology | Lifetime | 2 | NL 1 | 99.96 |
| Animal Virus Infections Studies | Lifetime | 5 | NL 1 | 99.91 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 11 | NL 1 | 99.89 |
| Viral Infections and Immunology Research | Lifetime | 18 | NL 2 | 99.71 |
| Animal Disease Management and Epidemiology | Lifetime | 25 | NL 3 | 99.70 |
| Respiratory viral infections research | Lifetime | 38 | NL 2 | 99.77 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 18 | NL 1 | 99.70 |
| Viral Infections and Vectors | Lifetime | 78 | NL 2 | 99.60 |
| SARS-CoV-2 detection and testing | Lifetime | 27 | NL 1 | 99.21 |
| COVID-19 Clinical Research Studies | Lifetime | 162 | NL 5 | 99.14 |
| Influenza Virus Research Studies | Lifetime | 77 | NL 3 | 99.45 |
| Zoonotic diseases and public health | Lifetime | 31 | NL 1 | 99.29 |
| Virus-based gene therapy research | Lifetime | 272 | NL 7 | 99.09 |
| Viral Infections and Outbreaks Research | Lifetime | 84 | NL 1 | 99.04 |
| COVID-19 epidemiological studies | Lifetime | 144 | NL 4 | 98.68 |
| Mosquito-borne diseases and control | Lifetime | 452 | NL 8 | 98.66 |
| Virology and Viral Diseases | Lifetime | 230 | NL 5 | 97.85 |
| Salmonella and Campylobacter epidemiology | Lifetime | 268 | NL 6 | 98.33 |
| Infection Control and Ventilation | Lifetime | 99 | NL 1 | 97.53 |
| Poxvirus research and outbreaks | Lifetime | 399 | NL 2 | 93.05 |
| Bacillus and Francisella bacterial research | Lifetime | 724 | NL 17 | 90.93 |
| Data-Driven Disease Surveillance | Lifetime | 602 | NL 9 | 89.42 |
| Animal Diversity and Health Studies | Lifetime | 698 | NL 12 | 87.17 |
| Travel-related health issues | Lifetime | 918 | NL 29 | 78.62 |
| Zoonotic diseases and public health | 2021-2025 | 3 | NL 1 | 99.39 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 50 | NL 2 | 99.67 |
| Viral Infections and Vectors | 2021-2025 | 22 | NL 2 | 99.17 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 25 | NL 1 | 98.66 |
| Mosquito-borne diseases and control | 2021-2025 | 40 | NL 2 | 99.02 |
| SARS-CoV-2 detection and testing | 2021-2025 | 48 | NL 1 | 98.29 |
| Animal Disease Management and Epidemiology | 2021-2025 | 29 | NL 2 | 98.70 |
| Virology and Viral Diseases | 2021-2025 | 18 | NL 1 | 96.31 |
| COVID-19 Clinical Research Studies | 2021-2025 | 360 | NL 8 | 98.24 |
| Viral Infections and Outbreaks Research | 2021-2025 | 65 | NL 1 | 95.89 |
| COVID-19 epidemiological studies | 2021-2025 | 226 | NL 2 | 96.68 |
| Animal Virus Infections Studies | 2021-2025 | 182 | NL 1 | 94.56 |
| Influenza Virus Research Studies | 2021-2025 | 152 | NL 7 | 95.96 |
| Poxvirus research and outbreaks | 2021-2025 | 51 | NL 1 | 94.94 |
| Bacillus and Francisella bacterial research | 2021-2025 | 82 | NL 3 | 92.12 |
| Herpesvirus Infections and Treatments | 2021-2025 | 311 | NL 3 | 88.62 |
| Infection Control in Healthcare | 2021-2025 | 742 | NL 20 | 47.81 |
